Total Payments
$50,350
2024 Payments
$34,806
Companies
24
Transactions
128
Medicare Patients
2,303
Medicare Billing
$275,847
Payment Breakdown by Category
Other$31,309 (62.2%)
Consulting$15,402 (30.6%)
Food & Beverage$2,346 (4.7%)
Travel$1,293 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $25,459 | 32 | 50.6% |
| Consulting Fee | $15,402 | 7 | 30.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,850 | 6 | 11.6% |
| Food and Beverage | $2,346 | 73 | 4.7% |
| Travel and Lodging | $1,293 | 10 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $34,810 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13,939 | 17 | $0 (2022) |
| Promius Pharma LLC | $624.00 | 2 | $0 (2018) |
| ABBVIE INC. | $312.56 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $96.53 | 5 | $0 (2023) |
| Amgen Inc. | $95.37 | 5 | $0 (2022) |
| Genentech USA, Inc. | $86.99 | 2 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $47.74 | 2 | $0 (2023) |
| UCB, Inc. | $41.28 | 2 | $0 (2022) |
| Lilly USA, LLC | $37.58 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,806 | 65 | Eisai Inc. ($34,765) |
| 2023 | $64.30 | 3 | Jazz Pharmaceuticals Inc. ($27.73) |
| 2022 | $240.80 | 9 | AstraZeneca Pharmaceuticals LP ($100.00) |
| 2021 | $14,276 | 31 | AstraZeneca Pharmaceuticals LP ($13,839) |
| 2020 | $11.47 | 1 | Novartis Pharmaceuticals Corporation ($11.47) |
| 2018 | $790.67 | 12 | Promius Pharma LLC ($624.00) |
| 2017 | $160.68 | 7 | Genentech USA, Inc. ($86.99) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $112.70 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,190.00 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $162.41 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $113.12 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $456.25 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,095.00 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $129.98 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,920.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $912.50 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $117.47 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 532 | 653 | $152,707 | $57,119 |
| 2022 | 11 | 583 | 686 | $166,972 | $60,291 |
| 2021 | 9 | 582 | 697 | $194,513 | $75,202 |
| 2020 | 9 | 606 | 768 | $213,953 | $83,235 |
Total Patients
2,303
Total Services
2,804
Medicare Billing
$275,847
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 110 | 153 | $30,600 | $13,794 | 45.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 44 | 70 | $30,590 | $11,099 | 36.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 99 | $27,842 | $9,453 | 34.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 61 | $24,363 | $7,890 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 104 | $14,530 | $6,273 | 43.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 80 | 118 | $9,086 | $4,535 | 49.9% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Facility | 2023 | 21 | 21 | $8,105 | $2,119 | 26.1% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Facility | 2023 | 15 | 15 | $4,121 | $1,079 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,470 | $876.38 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 112 | 114 | $45,610 | $16,188 | 35.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 114 | 146 | $29,338 | $11,087 | 37.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 40 | 58 | $25,346 | $9,239 | 36.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 94 | 120 | $16,839 | $6,494 | 38.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 40 | $11,522 | $4,060 | 35.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 74 | 98 | $7,546 | $2,797 | 37.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 36 | $7,218 | $2,795 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $7,245 | $2,738 | 37.8% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Facility | 2022 | 21 | 21 | $7,472 | $2,208 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $6,491 | $1,875 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $2,345 | $811.84 | 34.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 177 | 191 | $74,490 | $29,370 | 39.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 146 | 181 | $36,200 | $14,062 | 38.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 43 | 73 | $31,901 | $12,175 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 85 | 105 | $14,698 | $5,843 | 39.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 41 | 41 | $14,112 | $5,554 | 39.4% |
About Dr. Justin Chandler, MD
Dr. Justin Chandler, MD is a Neurology healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1750657599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Chandler, MD has received a total of $50,350 in payments from pharmaceutical and medical device companies, with $34,806 received in 2024. These payments were reported across 128 transactions from 24 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($25,459).
As a Medicare-enrolled provider, Chandler has provided services to 2,303 Medicare beneficiaries, totaling 2,804 services with total Medicare billing of $275,847. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Danville, PA
- Active Since 03/27/2012
- Last Updated 11/01/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750657599
Products in Payments
- Leqembi (Drug) $34,745
- BRILINTA (Drug) $13,911
- Zembrace (Drug) $624.00
- UBRELVY (Drug) $312.56
- Aimovig (Biological) $77.90
- AJOVY (Biological) $59.58
- XYWAV (Drug) $47.74
- Fycompa (Drug) $44.96
- EMGALITY (Drug) $37.58
- NORTHERA (Drug) $37.20
- AUSTEDO (Drug) $36.95
- NOURIANZ (Drug) $34.90
- Briviact (Drug) $23.88
- Vimpat (Drug) $17.40
- ONZETRA Xsail (Drug) $16.88
- Trudhesa (Drug) $16.57
- NAMZARIC (Drug) $15.29
- KYNMOBI (Drug) $14.92
- NURTEC ODT (Drug) $14.45
- NUPLAZID (Drug) $13.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Danville
Dr. Anne Morse, Do, DO
Neurology — Payments: $431,331
Neurology $431,331
Dr. Said Ibrahimi, M.d, M.D
Neurology — Payments: $37,110
Neurology $37,110
Victor Owusu-Yaw, M.d, M.D
Neurology — Payments: $22,929
Neurology $22,929
Jesse Li, Md, MD
Neurology — Payments: $9,520
Neurology $9,520
Joshua Neucks, Md, MD
Neurology — Payments: $5,271
Neurology $5,271
Prateeka Koul, Md, MD
Neurology — Payments: $3,815
Neurology $3,815